Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Balloon guide catheter effect on first pass and revascularization success

Michael D Modzelewski, Sabrina M Perlman, Mark C Duggan, Conrad W Liang
doi: https://doi.org/10.1101/2023.05.11.23289886
Michael D Modzelewski
1KP Bernard J Tyson School of Medicine, Pasadena, CA
BA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: michael.d.modzelewski{at}kp.org
Sabrina M Perlman
1KP Bernard J Tyson School of Medicine, Pasadena, CA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark C Duggan
1KP Bernard J Tyson School of Medicine, Pasadena, CA
MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Conrad W Liang
1KP Bernard J Tyson School of Medicine, Pasadena, CA
2Department of Neurosurgery, KP Fontana Medical Center, Fontana, CA
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The benefit of balloon guide catheter (BGC) use in endovascular thrombectomy (EVT) of patients with acute ischemic stroke remains uncertain. This study assessed the influence of BGC use during EVT on first pass (FP) and revascularization (RV) success in a cohort of stroke patients from a multi-hospital health system.

Methods Patients with anterior circulation large vessel occlusion (LVO) undergoing EVT with stent-retriever or aspiration between 2012 and 2018 at three Kaiser Permanente Southern California (KPSC) region hospitals were identified. A chi-squared test compared the relationship of BGC use with the primary outcomes of FP and RV success using a dichotomized thrombolysis in cerebral infarction (TICI) score of 2b or greater.

Results 218 patients were included. 35 (16%) underwent EVT with BGC. FP success rate did not significantly differ with 37.1% (95% CI 21.5% to 55.1%) FP success in patients that received EVT with BGC and 41.5% (95% CI 34.3% to 49.0%) in patients that received EVT without BGC (p = 0.71). Successful final RV did not significantly differ between the two groups with 85.7% (95% CI 69.7% to 95.2%) final RV success in the EVT with BGC group and 88.5% (95% CI 83.0% to 92.8%) in the EVT without BGC group (p = 0.78). There was no significant difference in FP (p = 0.88) or RV success (p = 0.42) between the BGC (37% FP and 86% RV), non-BGC stent-retriever (42% FP and 92% RV), and aspiration thrombectomy groups (41% FP and 86% RV).

Conclusion There was no observed association between BGC use in EVT of anterior circulation LVO and rates of first pass revascularization or final revascularization.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Kaiser Permanente Southern California (SCAL) IRB approval. IRB study number: 11566

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • Financial sponsorships: None

  • Conflict of interest disclorsures: None

  • List of commercial products

  • Merci® retriever, Stryker Corporation. Kalamazoo, MI, USA.

  • MindFrame Capture™ LP revascularization device, Medtronic. Minneapolis, MN, USA.

  • Solitaire™ revascularization device, Medtronic. Minneapolis, MN, USA.

  • Trevo® retriever, Stryker Corporation. Kalamazoo, MI, USA.

  • CELLO™ balloon guide catheter, Medtronic. Minneapolis, MN, USA.

  • FlowGate® balloon guide catheter, Stryker Corporation. Kalamazoo, MI, USA.

  • Address: 98 S. Los Robles Ave. Pasadena, CA 91101, Email: michael.d.modzelewski{at}kp.org

  • Address: 98 S. Los Robles Ave. Pasadena, CA 91101, Email: sabrina.m.perlman{at}kp.org

  • Address: 98 S. Los Robles Ave. Pasadena, CA 91101, Email: mark.c.duggan{at}kp.org

  • Address: 98 S. Los Robles Ave. Pasadena, CA 91101, Email: conrad.w.liang{at}kp.org

Data Availability

The data that support the findings of this study are available on request from the corresponding author, MM. The data are not publicly available due to their containing information that could compromise the privacy of research participants.

  • List of abbreviations

    BGC
    balloon guide catheter
    EVT
    endovascular thrombectomy
    FP
    first pass
    RV
    revascularization
    LVO
    large vessel occlusion
    KPSC
    Kaiser Permanente Southern California
    TICI
    thrombolysis in cerebral infarction
    MT
    mechanical thrombectomy
    SR
    stent retriever
    CAT
    contact aspiration thrombectomy
    NIHSS
    National Institute of Health Stroke Scale
    tPA
    tissue plasminogen activator
    AF
    atrial fibrillation
    SNF
    skilled nursing facility
    KP
    Kaiser Permanente
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted May 16, 2023.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Balloon guide catheter effect on first pass and revascularization success
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Balloon guide catheter effect on first pass and revascularization success
    Michael D Modzelewski, Sabrina M Perlman, Mark C Duggan, Conrad W Liang
    medRxiv 2023.05.11.23289886; doi: https://doi.org/10.1101/2023.05.11.23289886
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Balloon guide catheter effect on first pass and revascularization success
    Michael D Modzelewski, Sabrina M Perlman, Mark C Duggan, Conrad W Liang
    medRxiv 2023.05.11.23289886; doi: https://doi.org/10.1101/2023.05.11.23289886

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Radiology and Imaging
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)